The Food and Drug Administration began holding a special COVID-19 briefing today at 10 a.m. after halting the Johnson & Johnson vaccine.
The FDA and CDC announced that a review of the vaccine is underway after six U.S. cases were reported of a rare and severe type of blood clot in individuals after receiving the immunization.
White House COVID-19 Response Coordinator Jeff Zients said, "As FDA and CDC announced earlier today, out of an abundance of caution, they have recommended a pause in the use of the Johnson & Johnson vaccine as they review data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. The FDA and CDC will be providing details at their briefing."
Listen to the LIVE Call below:
Your health is important. Do you have questions about nutrition, weight loss, boosting immunity or medicine? Learn more here!